drugset / Trial / NCT02175901

Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication

NCT02175901

Phase 4 Completed 215 enrolled Shanghai Jiao Tong University School of Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

No trial has examined the the efficacy of amoxicillin and metronidazole based quadruple therapy for Helicobacter pylori treatment. The study aims to compare the effectiveness and safety of 14-day amoxicillin-/metronidazole-based quadruple regiment and classical quadruple regiment for Helicobacter pylori eradication.

Timeline

Start
2014-07
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clarithromycin Small molecule 500 mg
Subject Metronidazole Small molecule 400 mg
Background Amoxicillin Other / unclassified 1000 mg
Background Bismuth Potassium Citrate Unknown 220 mg
Background Lansoprazole Other / unclassified 30 mg